Striking deposition of toxic eosinophil major basic protein in mucus: Implications for chronic rhinosinusitis  Jens U. Ponikau, MD, David A. Sherris,

Slides:



Advertisements
Similar presentations
Nasal challenge with allergen leads to maxillary sinus inflammation
Advertisements

Are leukocytes in asthmatic patients aging faster
Douglas A. Plager, PhD, Ellen A. Weiss, Gail M. Kephart, BS, Robert M
Asthma inflammatory phenotypes show differential microRNA expression in sputum  Tania Maes, PhD, Francisco Avila Cobos, MSc, Florence Schleich, MD, PhD,
The antimicrobial protein short palate, lung, and nasal epithelium clone 1 (SPLUNC1) is differentially modulated in eosinophilic and noneosinophilic chronic.
Douglas A. Plager, PhD, Ellen A. Weiss, Gail M. Kephart, BS, Robert M
Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic.
Disease-specific expression and regulation of CCAAT/enhancer-binding proteins in asthma and chronic obstructive pulmonary disease  Peter Borger, PhD,
Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps  Bruce K. Tan, MD, Quan-Zhen Li, PhD, Lydia.
IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis  Hyun-Woo Shin, MD, PhD, Dong-Kyu Kim, MD, Min-Hyun Park, MD,
Airway epithelial cells in asthma
Increased TGF-β2 in severe asthma with eosinophilia
Extracellular eosinophilic traps in association with Staphylococcus aureus at the site of epithelial barrier defects in patients with severe airway inflammation 
Treatment of chronic rhinosinusitis with intranasal amphotericin B: A randomized, placebo-controlled, double-blind pilot trial  Jens U. Ponikau, MD, David.
Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome 
Chronic rhinosinusitis in Asia
Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic.
Electron microscopy elucidates eosinophil degranulation patterns in patients with eosinophilic esophagitis  Hedieh Saffari, PhD, Laura H. Hoffman, BSc,
Evidence of a role for B cell–activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps  Atsushi Kato, PhD,
Asthma therapy and airway remodeling
Pathophysiology of severe asthma
Increased expression of CC chemokine ligand 18 in patients with chronic rhinosinusitis with nasal polyps  Sarah Peterson, MD, Julie A. Poposki, MS, Deepti.
Susan C. Foley, MD, David Préfontaine, MSc, Qutayba Hamid, MD, PhD 
Kathleen R. Bartemes, BA, Gail M. Kephart, BS, Stephanie J
Interactions of eosinophil granule proteins with skin
The usefulness of measuring tear periostin for the diagnosis and management of ocular allergic diseases  Hiroshi Fujishima, MD, Naoko Okada, PhD, Kenji.
Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma  Margaret M. Kelly, MB, PhD,
Bronchial mucosal IFN-α/β and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations  Jie Zhu,
Cigarette smoke combined with Toll-like receptor 3 signaling triggers exaggerated epithelial regulated upon activation, normal T-cell expressed and secreted/CCL5.
David D. Tieu, MD, Anju T. Peters, MD, Roderick T
Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis  Deepti R. Nagarkar, PhD, Julie A. Poposki,
Expression of the cysteinyl leukotriene receptors cysLT1 and cysLT2 in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis  Chris Corrigan,
Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease  Xin Feng, MD, Madison K. Ramsden, BS, Julie Negri,
Src homology 2 domain–containing inositol 5-phosphatase 1 deficiency leads to a spontaneous allergic inflammation in the murine lung  Sun-Young Oh, PhD,
The role of the mast cell in the pathophysiology of asthma
Local allergic reaction in food-hypersensitive adults despite a lack of systemic food- specific IgE  Xiao Ping Lin, MD a, Jenny Magnusson, BSc a,b, Staffan.
Ovalbumin content of influenza vaccines
Increased noneosinophilic nasal polyps in chronic rhinosinusitis in US second- generation Asians suggest genetic regulation of eosinophilia  Mahboobeh.
Are leukocytes in asthmatic patients aging faster
Glandular mast cells with distinct phenotype are highly elevated in chronic rhinosinusitis with nasal polyps  Tetsuji Takabayashi, MD, Atsushi Kato, PhD,
CC chemokine receptors CCR1 and CCR4 are expressed on airway mast cells in allergic asthma  Kawa Amin, PhD, Christer Janson, MD, PhD, Ilkka Harvima, MD,
IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis  Hyun-Woo Shin, MD, PhD, Dong-Kyu Kim, MD, Min-Hyun Park, MD,
Zheng Liu, MD, Jean Kim, MD, PhD, Joseph P
Devyani Lal, MD, Benjamin L. Wright, MD, Kelly P. Shim, BS, Matthew A
Aspirin-sensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal inflammatory cells  Sun Ying, MD, PhD,
Primary immunodeficiency disorder caused by phosphoinositide 3–kinase δ deficiency  Georgios Sogkas, MD, PhD, Mykola Fedchenko, MD, Akshay Dhingra, MSc,
Anti–IL-5 (mepolizumab) therapy for eosinophilic esophagitis
Correlation between CCL26 production by human bronchial epithelial cells and airway eosinophils: Involvement in patients with severe eosinophilic asthma 
Diffuse pulmonary infiltrates in an immunocompromised patient
John Starr, MD, John H. Pruett, PhD, John W. Yunginger, MD, Gerald J
Airway remodeling and inflammation in competitive swimmers training in indoor chlorinated swimming pools  Valérie Bougault, PhD, Lionel Loubaki, MSc,
Long-term pathologic consequences of acute irritant-induced asthma
Anti–IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis  Iris M. Otani, MD, Arjun A. Anilkumar,
Esophageal eosinophilia caused by milk proteins: From suspicion to evidence based on 2 case reports  Soledad Terrados Cepeda, MD, Dario Antolin-Amerigo,
Douglas A. Plager, PhD, Ellen A. Weiss, Gail M. Kephart, BS, Robert M
Long-lasting effects of sublingual immunotherapy according to its duration: A 15-year prospective study  Maurizio Marogna, MD, Igino Spadolini, MD, Alessandro.
Eyal Grunebaum, MD, Ernest Cutz, MD, Chaim M. Roifman, MD 
Alvaro A. Cruz, MD, Robert M
Nasal challenge with allergen leads to maxillary sinus inflammation
Eosinophil and neutrophil extracellular DNA traps in human allergic asthmatic airways  Ryszard Dworski, MD, PhD, Hans-Uwe Simon, MD, PhD, Aimee Hoskins,
Mice deficient in the St3gal3 gene product α2,3 sialyltransferase (ST3Gal-III) exhibit enhanced allergic eosinophilic airway inflammation  Takumi Kiwamoto,
IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: Effect of immunotherapy  Kayhan T. Nouri-Aria, PhD, FRCPath, Charles.
Allergic fungal sinusitis: An immunohistologic analysis
Jens U. Ponikau, MD, David A. Sherris, MD, Hirohito Kita, MD, Eugene B
Large-scale gene expression profiling reveals distinct type 2 inflammatory patterns in chronic rhinosinusitis subtypes  Matthew A. Tyler, MD, Chris B.
Mice deficient in the St3gal3 gene product α2,3 sialyltransferase (ST3Gal-III) exhibit enhanced allergic eosinophilic airway inflammation  Takumi Kiwamoto,
Immunopathology of atopic dermatitis
Differences in airway remodeling between subjects with severe and moderate asthma  Carmela Pepe, MD, Susan Foley, MD, Joanne Shannon, MD, Catherine Lemiere,
Progression of asthma in childhood
Aarti Shikotra, BSc, David F. Choy, BSc, Chandra M
Presentation transcript:

Striking deposition of toxic eosinophil major basic protein in mucus: Implications for chronic rhinosinusitis  Jens U. Ponikau, MD, David A. Sherris, MD, Gail M. Kephart, BS, Eugene B. Kern, MD, David J. Congdon, MD, Cheryl R. Adolphson, MS, Margaret J. Springett, BS, Gerald J. Gleich, MD, Hirohito Kita, MD  Journal of Allergy and Clinical Immunology  Volume 116, Issue 2, Pages 362-369 (August 2005) DOI: 10.1016/j.jaci.2005.03.049 Copyright © 2005 American Academy of Allergy, Asthma and Immunology Terms and Conditions

Fig 1 Photomicrographs of CRS specimens stained for MBP by means of immunofluorescence or stained with hematoxylin and eosin. Panel a demonstrates eosinophilic inflammation in tissue, eosinophil clusters (black arrows) in mucus, subepithelial basement membrane thickening, and damaged epithelium (yellow arrows) (hematoxylin and eosin counterstain of Panel b; original magnification, 160×). Panel b shows MBP in tissue is contained within the cells or in intact granules (punctate staining) outside the cells. In mucus, diffuse MBP staining is in eosinophil clusters (white arrows) and outside of clusters (anti-MBP; original magnification, 160×). Panel c shows minimal tissue eosinophilia, massive eosinophilia in mucus, subepithelial basement membrane thickening, and the damaged epithelium (yellow arrows) (hematoxylin and eosin; original magnification, 400×). Panel d (serial section of Panel c) shows few intact eosinophils in tissue, intense diffuse MBP deposition within the mucus, and MBP adjacent to the epithelial surface (anti-MBP; original magnification, 400×). Panels e (tissue) and f (mucus) show intact eosinophils (white arrows) and free granules (punctate staining, blue arrows); diffuse extracellular MBP staining (orange arrows) appears unique to mucus (anti-MBP; original magnification, 1400×). Serial sections stained with normal rabbit IgG were negative (results not shown). Journal of Allergy and Clinical Immunology 2005 116, 362-369DOI: (10.1016/j.jaci.2005.03.049) Copyright © 2005 American Academy of Allergy, Asthma and Immunology Terms and Conditions

Fig 2 Comparisons of eosinophilic and neutrophilic inflammation in tissue versus mucus. The graphs show the mean MBP and elastase immunofluorescence scores for intact eosinophils and neutrophils, punctate staining (MBP and elastase within intact extracellular granules), and diffuse staining (extracellular MBP and elastase not in granules) in tissue and mucus from 22 patients with CRS. Each dot represents the mean score of 3 independent examiners for each patient (scoring on vertical axis follows the grading system presented in the Methods section). Panel a shows a CRS specimen stained with anti-MBP; note the abundant diffuse MBP in mucus that is absent in tissue. Panel b shows a CRS specimen stained with anti-elastase; note the virtual absence of diffuse elastase in both mucus and tissue (original magnification, 400×). Journal of Allergy and Clinical Immunology 2005 116, 362-369DOI: (10.1016/j.jaci.2005.03.049) Copyright © 2005 American Academy of Allergy, Asthma and Immunology Terms and Conditions

Fig 3 Comparison of digitized areas of minimal and maximal MBP or elastase staining in the tissue and mucus of patients with CRS. To demonstrate the heterogenicity within the 22 specimens, these data points represent the minimal and maximal percentages of area positive for MBP or elastase immunofluorescence. The horizontal lines show the median values in each group. Journal of Allergy and Clinical Immunology 2005 116, 362-369DOI: (10.1016/j.jaci.2005.03.049) Copyright © 2005 American Academy of Allergy, Asthma and Immunology Terms and Conditions

Fig 4 Transmission electron micrographs of sinus tissue from a patient with CRS. Panel a shows the characteristic electron-dense secondary granules within an intact cell (white arrows) and intact extracellular granules in the tissue (black arrows; original magnification, 10,000×). Panel b shows immunogold labeling (black dots) for MBP and demonstrates that MBP is localized within the intact granules; note the lack of MBP labeling in the surrounding tissue (original magnification, 33,000×). Journal of Allergy and Clinical Immunology 2005 116, 362-369DOI: (10.1016/j.jaci.2005.03.049) Copyright © 2005 American Academy of Allergy, Asthma and Immunology Terms and Conditions

Fig 5 MBP concentrations in mucus specimens from patients with CRS and healthy control subjects. Mucus specimens were extracted with 0.15 M NaCl, and MBP was measured in the supernatants by means of RIA. MBP was detected in the maxillary sinus mucus and in the nasal cavity mucus of patients with CRS but not in mucus from the healthy control subjects. Horizontal bars indicate mean values for each group. Journal of Allergy and Clinical Immunology 2005 116, 362-369DOI: (10.1016/j.jaci.2005.03.049) Copyright © 2005 American Academy of Allergy, Asthma and Immunology Terms and Conditions